The revision would be, its absolutely clear that zero [alcohol] is better than any
documented research protocols reference approximately 200 mcg per dose
T.van der SchaftJ.van Os-MedendorpH.et al (2019)
Systemic metabolic alterations and their relationship to neuropsychiatric symptomatology PAIS, including long COVID, as well as CFS and IMD, share the characteristic of systemic metabolic disturbances, which may be a sign of underlying multi-organ inflammation and exhaustion [31], and consequently may contribute to neuropsychiatric symptomatology, as many metabolites can cross the bloodbrain barrier (BBB) [30, 58] (e.g., short chain fatty acids (SCFAs) derived from the gut microbiota such as acetate [40], amino acids such as tryptophan [52] and also carnitine/acetylcarnitine can cross the BBB via transporters [59])

GLOW composition (verified from 99puritypeptides.com/product/glow/): GHK-Cu: 50mg (dominant) BPC-157: 10mg TB-500: 10mg KLOW composition (verified from 99puritypeptides.com/product/klow/): BPC-157: 50mg (dominant) TB-500: 10mg KPV: 10mg GHK-Cu: 10mg Why KPV Is in KLOW but Not GLOW GLOW is described on the 99 Purity Peptides product page as "a cosmetic-oriented skin and connective-tissue rejuvenation blend" research targeting dermal remodeling, collagen support, and skin elasticity
Fussner, L